These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 23659447

  • 1. A low dietary ratio of omega-6 to omega-3 Fatty acids may delay progression of prostate cancer.
    Apte SA, Cavazos DA, Whelan KA, Degraffenried LA.
    Nutr Cancer; 2013; 65(4):556-62. PubMed ID: 23659447
    [Abstract] [Full Text] [Related]

  • 2. Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2.
    Kobayashi N, Barnard RJ, Henning SM, Elashoff D, Reddy ST, Cohen P, Leung P, Hong-Gonzalez J, Freedland SJ, Said J, Gui D, Seeram NP, Popoviciu LM, Bagga D, Heber D, Glaspy JA, Aronson WJ.
    Clin Cancer Res; 2006 Aug 01; 12(15):4662-70. PubMed ID: 16899616
    [Abstract] [Full Text] [Related]

  • 3. Embelin inhibits growth and induces apoptosis through the suppression of Akt/mTOR/S6K1 signaling cascades.
    Kim SW, Kim SM, Bae H, Nam D, Lee JH, Lee SG, Shim BS, Kim SH, Ahn KS, Choi SH, Sethi G, Ahn KS.
    Prostate; 2013 Feb 15; 73(3):296-305. PubMed ID: 22887478
    [Abstract] [Full Text] [Related]

  • 4. The effects of omega-3 and omega-6 fatty acids on in vitro prostate cancer growth.
    Pandalai PK, Pilat MJ, Yamazaki K, Naik H, Pienta KJ.
    Anticancer Res; 1996 Feb 15; 16(2):815-20. PubMed ID: 8687134
    [Abstract] [Full Text] [Related]

  • 5. Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer.
    Wang S, Wu J, Suburu J, Gu Z, Cai J, Axanova LS, Cramer SD, Thomas MJ, Perry DL, Edwards IJ, Mucci LA, Sinnott JA, Loda MF, Sui G, Berquin IM, Chen YQ.
    Carcinogenesis; 2012 Feb 15; 33(2):404-12. PubMed ID: 22159221
    [Abstract] [Full Text] [Related]

  • 6. Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids.
    Berquin IM, Min Y, Wu R, Wu J, Perry D, Cline JM, Thomas MJ, Thornburg T, Kulik G, Smith A, Edwards IJ, D'Agostino R, Zhang H, Wu H, Kang JX, Chen YQ.
    J Clin Invest; 2007 Jul 15; 117(7):1866-75. PubMed ID: 17607361
    [Abstract] [Full Text] [Related]

  • 7. Expression of the fat-1 gene diminishes prostate cancer growth in vivo through enhancing apoptosis and inhibiting GSK-3 beta phosphorylation.
    Lu Y, Nie D, Witt WT, Chen Q, Shen M, Xie H, Lai L, Dai Y, Zhang J.
    Mol Cancer Ther; 2008 Oct 15; 7(10):3203-11. PubMed ID: 18852124
    [Abstract] [Full Text] [Related]

  • 8. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 15; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Omega-3 fatty acid inhibition of prostate cancer progression to hormone independence is associated with suppression of mTOR signaling and androgen receptor expression.
    Friedrichs W, Ruparel SB, Marciniak RA, deGraffenried L.
    Nutr Cancer; 2011 Mar 15; 63(5):771-7. PubMed ID: 21667400
    [Abstract] [Full Text] [Related]

  • 11. A comparative study of tissue ω-6 and ω-3 polyunsaturated fatty acids (PUFA) in benign and malignant pathologic stage pT2a radical prostatectomy specimens.
    Schumacher MC, Laven B, Petersson F, Cederholm T, Onelöv E, Ekman P, Brendler C.
    Urol Oncol; 2013 Apr 15; 31(3):318-24. PubMed ID: 21414816
    [Abstract] [Full Text] [Related]

  • 12. [Role of Rho GTPase in inhibiting metastatic ability of human prostate cancer cell line PC-3 by omega-3 polyunsaturated fatty acid].
    Yi L, Zhang QY, Mi MT.
    Ai Zheng; 2007 Dec 15; 26(12):1281-6. PubMed ID: 18076787
    [Abstract] [Full Text] [Related]

  • 13. Dietary fatty acids correlate with prostate cancer biopsy grade and volume in Jamaican men.
    Ritch CR, Wan RL, Stephens LB, Taxy JB, Huo D, Gong EM, Zagaja GP, Brendler CB.
    J Urol; 2007 Jan 15; 177(1):97-101; discussion 101. PubMed ID: 17162011
    [Abstract] [Full Text] [Related]

  • 14. Prostatic and dietary omega-3 fatty acids and prostate cancer progression during active surveillance.
    Moreel X, Allaire J, Léger C, Caron A, Labonté MÈ, Lamarche B, Julien P, Desmeules P, Têtu B, Fradet V.
    Cancer Prev Res (Phila); 2014 Jul 15; 7(7):766-76. PubMed ID: 24824038
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells.
    Schley PD, Jijon HB, Robinson LE, Field CJ.
    Breast Cancer Res Treat; 2005 Jul 15; 92(2):187-95. PubMed ID: 15986129
    [Abstract] [Full Text] [Related]

  • 16. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
    Chinni SR, Li Y, Upadhyay S, Koppolu PK, Sarkar FH.
    Oncogene; 2001 May 24; 20(23):2927-36. PubMed ID: 11420705
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Opposing effects of prepubertal low- and high-fat n-3 polyunsaturated fatty acid diets on rat mammary tumorigenesis.
    Olivo SE, Hilakivi-Clarke L.
    Carcinogenesis; 2005 Sep 24; 26(9):1563-72. PubMed ID: 15888492
    [Abstract] [Full Text] [Related]

  • 19. Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence.
    Astorg P.
    Cancer Causes Control; 2004 May 24; 15(4):367-86. PubMed ID: 15141138
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.